Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease

Lancet

Volumn 353, Issue 9161, 1999, Pages 1329-1330

  Clarke, C E ^a,b   Ray, P S ^a,b   Speller, J M ^a,b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

EID: 0033577454     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00147-6     Document Type: Article

References (3)

1. Thomaides TN, Chaudhuri KR, Maule S, Watson L, Marsden CD, Mathias CJ. Growth hormone response to clonidine in central and peripheral primary autonomie failure. Lancet 1 992; 340: 263-66.
2. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth hormone release with clonidine. Lancet 1997; 349: 1877-81.
3. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1 994: 262-81.